The Efficacy and Safety of Acellular Matrix Therapy for Diabetic Foot Ulcers: A Meta-Analysis of Randomized Clinical Trials

<table class="table-group" id="tab2"><tr><td><table class="table"><tr><td class="thead-hr" colspan="3"><hr/></td></tr><tr class="thead"><td class="align_left" rowspan="2">Outcome</td><td class="align_center" colspan="2">P</td></tr><tr class="thead"><td class="align_center">Egger’s test</td><td class="align_center">Begg’s test</td></tr><tr><td class="thead-hr" colspan="3"><hr/></td></tr><tr><td class="align_left">Complete healing rate at 12 weeks</td><td class="align_center">0.617</td><td class="align_center">1.000</td></tr><tr><td class="align_left">Time to complete heal</td><td class="align_center">0.438</td><td class="align_center">0.806</td></tr><tr><td class="align_left">Adverse events</td><td class="align_center">0.766</td><td class="align_center">0.754</td></tr><tr class="table-tr"><td colspan="3"><hr class="tbody-hr"/></td></tr></table></td></tr></table>

<div>Egger’s test and Begg’s test for the outcomes.</div>

Journal of Diabetes Research

tab2

Table 2

Table 2: The Efficacy and Safety of Acellular Matrix Therapy for Diabetic Foot Ulcers: A Meta-Analysis of Randomized Clinical Trials 